Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Biotech’s Year-End To-Do List

TheMotleyFool

0 0

Biotech’s Year-End To-Do ListPhoto, wide shot, wide-angle lens, Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png

Before we ring in 2020, December will be ripe for swings in biotech stock prices. 2019 started strong, waned, and then regained momentum amid a slew of successful clinical trial results, several acquisition announcements, and positive drug approval decisions that came often months ahead of the U.S. Food and Drug Administration's own deadlines.

Additionally, the looming unknown of who will be the next head of the FDA was answered when President Trump nominated Dr. Stephen Hahn this week.

Image Source: Getty Images.

Source Fool.com

Like: 0

PBYI

Teilen